Worldwide,∼ 4 million people die from sudden cardiac death every year caused in more
than half of the cases by ischaemic cardiomyopathy (ICM). Prevention of sudden cardiac …

Background It is unknown whether implantable cardioverter-defibrillator (ICD) discharges
actively contribute to a worse prognosis independent of the underlying arrhythmia. There is …

Implantable cardioverter-defibrillator (ICD) therapy is clearly an effective therapy for selected
patients in definable populations. The benefits and risks of ICD therapy are directly impacted …

Background: Catheter ablation for ventricular tachycardia (VT) reduces the recurrence of VT
in patients with implantable cardioverter-defibrillators (ICDs). The appropriate timing of VT …

Background—Appropriate guideline criteria for use of implantable cardioverter-defibrillators
(ICDs) do not take into account potential recovery of left ventricular ejection fraction (LVEF) …

Background—The benefit of novel implantable cardioverter defibrillator (ICD) programming
in reducing inappropriate ICD therapy and mortality was demonstrated in Multicenter …

To develop a suite of quality indicators (QIs) for the management of patients with ventricular
arrhythmias (VA) and the prevention of sudden cardiac death (SCD). The Working Group …

Objectives This study sought to analyze safety and outcomes of ventricular tachycardia (VT)
substrate ablation during sinus rhythm (SR), without baseline VT induction. Background …

Catheter Ablation for Ventricular Tachycardia Introduction We conducted this pilot
randomized clinical trial to determine the feasibility of a large clinical trial aimed at testing …

Background In transvenous implantable cardioverter-defibrillator (TV-ICD) implants, routine
defibrillation testing (DFT) does not improve shock efficacy or reduce arrhythmic death but …